Zhengxiao L. Ouyang

No 139 Renmin Road
Changsha, 410011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Targeting TLR4/non-canonical NF-κB pathway by Bushen Bitong recipe enhances BMSCs-based cartilage repair in osteoarthritis.

Targeting TLR4/non-canonical NF-κB pathway by Bushen Bitong recipe enhances BMSCs-based cartilage repair in osteoarthritis.

Journal: Biochemistry and biophysics reports

Published: November 19, 2025

Association between night shift work and risk of osteoporosis and osteoporosis-related pathological fracture.

Association between night shift work and risk of osteoporosis and osteoporosis-related pathological fracture.

Journal: Frontiers in public health

Published: October 07, 2025

Corrigendum to "Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-κB and JNK signaling pathways during osteoporosis treatment" [Biochem. Biophys. Res. Commun. 509 (2019) 294-300].

Corrigendum to "Proanthocyanidins inhibit osteoclast formation and function by inhibiting the NF-κB and JNK signaling pathways during osteoporosis treatment" [Biochem. Biophys. Res. Commun. 509 (2019) 294-300].

Journal: Biochemical and biophysical research communications

Published: September 20, 2025

Correction: Cimifugin suppresses NF-κB signaling to prevent osteoclastogenesis and periprosthetic osteolysis.

Correction: Cimifugin suppresses NF-κB signaling to prevent osteoclastogenesis and periprosthetic osteolysis.

Journal: Frontiers in pharmacology

Published: August 02, 2025

Correction: Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-κB signaling pathway of osteoclasts.

Correction: Punicalin attenuates breast cancer-associated osteolysis by inhibiting the NF-κB signaling pathway of osteoclasts.

Journal: Frontiers in pharmacology

Published: August 02, 2025

Correction: Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3/c-Jun activation.

Correction: Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3/c-Jun activation.

Journal: Frontiers in pharmacology

Published: August 02, 2025

Correction: Rubidium chloride targets Jnk/p38-mediated NF-κB activation to attenuate osteoclastogenesis and facilitate osteoblastogenesis.

Correction: Rubidium chloride targets Jnk/p38-mediated NF-κB activation to attenuate osteoclastogenesis and facilitate osteoblastogenesis.

Journal: Frontiers in pharmacology

Published: August 02, 2025

Walking pace and its association with osteoporosis and pathological fractures: insights from UK biobank.

Walking pace and its association with osteoporosis and pathological fractures: insights from UK biobank.

Journal: Frontiers in endocrinology

Published: May 27, 2025

Phase Ⅲ, multicenter, randomized comparative study of LY01005 and Zoladex® for patients with premenopausal breast cancer

Phase Ⅲ, multicenter, randomized comparative study of LY01005 and Zoladex® for patients with premenopausal breast cancer

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: April 23, 2025

Correction: Wang et al. The Inhibition of RANKL-Induced Osteoclastogenesis through the Suppression of p38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis. Int. J. Mol. Sci. 2014, 15, 21913-21934.

Correction: Wang et al. The Inhibition of RANKL-Induced Osteoclastogenesis through the Suppression of p38 Signaling Pathway by Naringenin and Attenuation of Titanium-Particle-Induced Osteolysis. Int. J. Mol. Sci. 2014, 15, 21913-21934.

Journal: International journal of molecular sciences

Published: March 22, 2025

Mechanism of EC-EXOs-Derived THBS3 Targeting CD47 to Regulate BMSCs Differentiation to Ameliorate Bone Loss.

Mechanism of EC-EXOs-Derived THBS3 Targeting CD47 to Regulate BMSCs Differentiation to Ameliorate Bone Loss.

Journal: Cell proliferation

Published: February 07, 2025

Posterior cruciate ligament reconstruction without tourniquet use reduces joint swelling without compromising surgical outcomes: a retrospective study.

Posterior cruciate ligament reconstruction without tourniquet use reduces joint swelling without compromising surgical outcomes: a retrospective study.

Journal: Scientific reports

Published: November 30, 2024

Showing 1-12 of 93

Last Updated: 09/26/2026